973 related articles for article (PubMed ID: 14607925)
21. Regulation of bcl-xL expression and Fas susceptibility in mouse B cells by CD40 ligation, surface IgM crosslinking and IL-4.
Koizumi T; Wang J; Suzuki Y; Masuda K; Watanabe T
Mol Immunol; 1996 Nov; 33(16):1247-53. PubMed ID: 9129161
[TBL] [Abstract][Full Text] [Related]
22. Complement component C3d-antigen complexes can either augment or inhibit B lymphocyte activation and humoral immunity in mice depending on the degree of CD21/CD19 complex engagement.
Lee Y; Haas KM; Gor DO; Ding X; Karp DR; Greenspan NS; Poe JC; Tedder TF
J Immunol; 2005 Dec; 175(12):8011-23. PubMed ID: 16339538
[TBL] [Abstract][Full Text] [Related]
23. Distinct molecular mechanisms of Fas resistance in murine B lymphoma cells.
Mueller CM; Scott DW
J Immunol; 2000 Aug; 165(4):1854-62. PubMed ID: 10925264
[TBL] [Abstract][Full Text] [Related]
24. alpha-fetoprotein causes apoptosis in tumor cells via a pathway independent of CD95, TNFR1 and TNFR2 through activation of caspase-3-like proteases.
Dudich E; Semenkova L; Dudich I; Gorbatova E; Tochtamisheva N; Tatulov E; Nikolaeva M; Sukhikh G
Eur J Biochem; 1999 Dec; 266(3):750-61. PubMed ID: 10583368
[TBL] [Abstract][Full Text] [Related]
25. Theileria parva-transformed T cells show enhanced resistance to Fas/Fas ligand-induced apoptosis.
Küenzi P; Schneider P; Dobbelaere DA
J Immunol; 2003 Aug; 171(3):1224-31. PubMed ID: 12874209
[TBL] [Abstract][Full Text] [Related]
26. Coligation of the B cell receptor with complement receptor type 2 (CR2/CD21) using its natural ligand C3dg: activation without engagement of an inhibitory signaling pathway.
Lyubchenko T; dal Porto J; Cambier JC; Holers VM
J Immunol; 2005 Mar; 174(6):3264-72. PubMed ID: 15749857
[TBL] [Abstract][Full Text] [Related]
27. Cutting edge: recruitment of the CD19/CD21 coreceptor to B cell antigen receptor is required for antigen-mediated expression of Bcl-2 by resting and cycling hen egg lysozyme transgenic B cells.
Roberts T; Snow EC
J Immunol; 1999 Apr; 162(8):4377-80. PubMed ID: 10201971
[TBL] [Abstract][Full Text] [Related]
28. Mitogen-activated protein kinase/extracellular signal-regulated kinase signaling in activated T cells abrogates TRAIL-induced apoptosis upstream of the mitochondrial amplification loop and caspase-8.
Söderström TS; Poukkula M; Holmström TH; Heiskanen KM; Eriksson JE
J Immunol; 2002 Sep; 169(6):2851-60. PubMed ID: 12218097
[TBL] [Abstract][Full Text] [Related]
29. Hepatitis C virus protects human B lymphocytes from Fas-mediated apoptosis via E2-CD81 engagement.
Chen Z; Zhu Y; Ren Y; Tong Y; Hua X; Zhu F; Huang L; Liu Y; Luo Y; Lu W; Zhao P; Qi Z
PLoS One; 2011 Apr; 6(4):e18933. PubMed ID: 21526201
[TBL] [Abstract][Full Text] [Related]
30. Mitochondria-dependent caspase-9 activation is necessary for antigen receptor-mediated effector caspase activation and apoptosis in WEHI 231 lymphoma cells.
Herold MJ; Kuss AW; Kraus C; Berberich I
J Immunol; 2002 Apr; 168(8):3902-9. PubMed ID: 11937545
[TBL] [Abstract][Full Text] [Related]
31. In the erythroleukemic cell line HEL Prostate-apoptosis-response-gene-4 (par-4) fails to down-regulate Bcl-2 and to promote apoptosis.
Boehrer S; Brieger A; Schaaf S; Kukoc-Zivojnov N; Nowak D; Ruthardt M; Hoelzer D; Mitrou PS; Weidmann E; Chow KU
Leuk Lymphoma; 2004 Jul; 45(7):1445-51. PubMed ID: 15359646
[TBL] [Abstract][Full Text] [Related]
32. Fas resistance of leukemic eosinophils is due to activation of NF-kappa B by Fas ligation.
Qin Y; Camoretti-Mercado B; Blokh L; Long CG; Ko FD; Hamann KJ
J Immunol; 2002 Oct; 169(7):3536-44. PubMed ID: 12244143
[TBL] [Abstract][Full Text] [Related]
33. Progressive resistance to apoptosis in a cell lineage model of human proliferative breast disease.
Starcevic SL; Elferink C; Novak RF
J Natl Cancer Inst; 2001 May; 93(10):776-82. PubMed ID: 11353788
[TBL] [Abstract][Full Text] [Related]
34. Rapid up-regulation of c-FLIP expression by BCR signaling through the PI3K/Akt pathway inhibits simultaneously induced Fas-mediated apoptosis in murine B lymphocytes.
Moriyama H; Yonehara S
Immunol Lett; 2007 Mar; 109(1):36-46. PubMed ID: 17275920
[TBL] [Abstract][Full Text] [Related]
35. c-Rel is required for the protection of B cells from antigen receptor-mediated, but not Fas-mediated, apoptosis.
Owyang AM; Tumang JR; Schram BR; Hsia CY; Behrens TW; Rothstein TL; Liou HC
J Immunol; 2001 Nov; 167(9):4948-56. PubMed ID: 11673501
[TBL] [Abstract][Full Text] [Related]
36. CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway.
Schattner EJ; Elkon KB; Yoo DH; Tumang J; Krammer PH; Crow MK; Friedman SM
J Exp Med; 1995 Nov; 182(5):1557-65. PubMed ID: 7595225
[TBL] [Abstract][Full Text] [Related]
37. Transfection of caspase-3 in the caspase-3-deficient Hodgkin's disease cell line, KMH2, results in enhanced sensitivity to CD95-, TRAIL-, and ARA-C-induced apoptosis.
Wrone-Smith T; Izban KF; Ergin M; Cosar EF; Hsi ED; Alkan S
Exp Hematol; 2001 May; 29(5):572-81. PubMed ID: 11376869
[TBL] [Abstract][Full Text] [Related]
38. Constitutive caspase activation and impaired death-inducing signaling complex formation in CD95-resistant, long-term activated, antigen-specific T cells.
Strauss G; Knape I; Melzner I; Debatin KM
J Immunol; 2003 Aug; 171(3):1172-82. PubMed ID: 12874203
[TBL] [Abstract][Full Text] [Related]
39. Complement receptors regulate differentiation of bone marrow plasma cell precursors expressing transcription factors Blimp-1 and XBP-1.
Gatto D; Pfister T; Jegerlehner A; Martin SW; Kopf M; Bachmann MF
J Exp Med; 2005 Mar; 201(6):993-1005. PubMed ID: 15767369
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of Fas-mediated apoptosis by the B cell antigen receptor through c-FLIP.
Wang J; Lobito AA; Shen F; Hornung F; Winoto A; Lenardo MJ
Eur J Immunol; 2000 Jan; 30(1):155-63. PubMed ID: 10602037
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
